| Factors |
Unadjusted |
Adjusted |
| OR |
95% CI |
p |
OR |
95% CI |
p |
| Demographic Characteristics |
|
|
|
|
|
|
|
|
| Age |
|
|
|
1.000 |
|
|
|
0.838 |
| 40-49 vs. 30-39 |
0.98 |
0.21 |
4.57 |
0.978 |
1.80 |
0.20 |
16.42 |
0.604 |
| 50-59 vs. 30-39 |
1.04 |
0.22 |
4.85 |
0.958 |
3.17 |
0.26 |
38.81 |
0.367 |
| 60+ vs. 30-39 |
1.03 |
0.15 |
7.02 |
0.979 |
2.96 |
0.13 |
66.31 |
0.493 |
| |
|
|
|
|
|
|
|
|
| Female vs. Male |
0.82 |
0.24 |
2.82 |
0.750 |
0.72 |
0.12 |
4.42 |
0.727 |
| |
|
|
|
|
|
|
|
|
| Ethnicity |
|
|
|
0.655 |
|
|
|
0.916 |
| API/other vs. White |
0.92 |
0.23 |
3.74 |
0.911 |
1.31 |
0.14 |
12.58 |
0.816 |
| Hispanic/Latino vs. White |
0.51 |
0.12 |
2.17 |
0.361 |
0.78 |
0.08 |
7.77 |
0.829 |
| |
|
|
|
|
|
|
|
|
| Hematologist-Oncologist/Radiation Oncologist vs. Medical Oncologists |
0.63 |
0.18 |
2.22 |
0.477 |
0.83 |
0.11 |
6.48 |
0.862 |
| |
|
|
|
|
|
|
|
|
| Academic/Teaching Hospital/Other vs. Private Practice |
3.38 |
0.90 |
12.76 |
0.072 |
3.66 |
0.58 |
23.13 |
0.168 |
| |
|
|
|
|
|
|
|
|
| Promoters |
|
|
|
|
|
|
|
|
| Personal benefits |
1.15 |
0.67 |
1.97 |
0.604 |
1.29 |
0.55 |
3.02 |
0.553 |
| Trial treatment benefits |
1.23 |
0.74 |
2.05 |
0.414 |
1.46 |
0.64 |
3.34 |
0.373 |
| Comfortable explaining CT to patients |
1.14 |
0.65 |
1.97 |
0.651 |
0.71 |
0.28 |
1.80 |
0.472 |
| Patients are followed closely |
0.97 |
0.56 |
1.68 |
0.919 |
0.89 |
0.36 |
2.19 |
0.800 |
| Psychosocial benefit |
1.86 |
1.06 |
3.27 |
0.029 |
2.09 |
0.80 |
5.47 |
0.135 |
| |
|
|
|
|
|
|
|
|
| Logistical barriers |
|
|
|
|
|
|
|
|
| CT process burden |
0.35 |
0.17 |
0.70 |
0.003 |
0.28 |
0.08 |
0.94 |
0.040 |
| Coordination with CT site/involvement |
0.84 |
0.48 |
1.44 |
0.523 |
1.53 |
0.57 |
4.09 |
0.394 |
| |
|
|
|
|
|
|
|
|
| Personal barriers |
|
|
|
|
|
|
|
|
| Personal/attitudes |
0.87 |
0.51 |
1.47 |
0.597 |
2.04 |
0.72 |
5.77 |
0.180 |
| Lack of personal benefits |
0.41 |
0.23 |
0.74 |
0.003 |
0.49 |
0.20 |
1.19 |
0.116 |
| Lack of awareness about EPCT |
1.11 |
0.64 |
1.94 |
0.714 |
1.31 |
0.53 |
3.22 |
0.554 |
| |
|
|
|
|
|
|
|
|
| Trial-related barriers |
|
|
|
|
|
|
|
|
| Protocol complexity |
0.40 |
0.20 |
0.79 |
0.008 |
0.53 |
0.13 |
2.15 |
0.376 |
| Trial treatment |
1.43 |
0.79 |
2.59 |
0.239 |
0.79 |
0.31 |
1.99 |
0.615 |
